CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to ABBV

Upadacitinib

Phase 3
AbbVie Inc. (ABBV)

Phase 3

Development Phase

2

Upcoming Catalysts

1

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Sep '27
ABBVPhase 3

Upadacitinib Phase 3 Est. Readout

Upadacitinib
Sep 2027~
CT.gov
00%
Jun '27
ABBVPhase 3

Upadacitinib Phase 3 Est. Readout

Upadacitinib
Jun 2027~
CT.gov
00%
Development History
Nov '26
ABBVPhase 3

Upadacitinib Phase 3 Est. Readout (Switch-Up)

Upadacitinib
Nov 2026~
CT.gov
00%
Competitive Landscape

0 competitors in Ulcerative Colitis (UC)

View Full Landscape
Drug Information

Target Indication

Ulcerative Colitis (UC)

Clinical Trial

NCT03653026

Last updated: 1/2/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.